Every second colorectal cancer diagnosis is made too late¹
Colorectal cancer screening is that simple at the European Oncology Lab
-
Stool test online
order -
Comfortable at home
Take samples -
Samples to our laboratory
return -
Results received within a few days
How does the blood in stool test work?
The iFOBT is a test for the early detection of colorectal cancer that reliably detects occult (i.e., invisible) blood in stool . Unlike classic tests such as the guaiac test, the immunochemical fecal occult blood test (iFOBT) only reacts to human blood, which significantly increases its accuracy.
The procedure is straightforward: Take a stool sample at home , seal it in the sample tube and send it to our certified laboratory.
An abnormal result can indicate precancerous lesions or other changes in the intestine . This stool test is a low-threshold and effective alternative, especially for people who do not want to undergo a colonoscopy .
iFOBT compared to other stool tests
The iFOBT is a well-established and widely used method. However, newer methods are now available, such as tumor DNA stool tests . These analyze genetic material in stool and can, in some cases, detect colorectal cancer in its early stages – even without the presence of blood.
The advantages of the iFOBT are its ease of use, good availability, and low cost. This makes the stool test ideal for regular preventative care.
Tumor DNA tests such as ColoAlert, on the other hand, offer a higher level of sensitivity, but are more expensive and are not always covered by health insurance.
Conclusion : The iFOBT stool test remains an important tool in colorectal cancer screening – especially when used regularly.
Our recommendation: ColoAlert for earlier colorectal cancer detection
The IFOB test is a good start and certainly better than doing nothing. However, analyzing for hidden blood in stool does not detect all tumors in time . ColoAlert is a new stool test that examines stool samples for the presence of tumor DNA – thus identifying affected individuals at earlier stages.⁴⸴⁵ ColoAlert is reimbursable for those with private health insurance.
Why the immunochemical fecal occult blood test (iFOBT) is also useful before the age of 50.
Colorectal cancer is no longer a disease that only affects older people. Studies show that the number of diagnoses in younger people between the ages of 20 and 49 is steadily increasing.² Unfortunately, awareness of the disease is often lacking in this age group, which can lead to symptoms being overlooked or misinterpreted .
The IFOB test offers you the opportunity to detect signs of colorectal cancer – simply and precisely. Especially if additional risk factors such as a family history of the disease, an unhealthy diet, or lack of exercise are present,³ screening before the expected age can be beneficial.